Oncology Medical News about Pim-1 expression

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines
Experimental Hematology, 10/22/09

Li J et al. – Pim–1 is variably expressed in leukemia cell lines and associated with drug resistance. Targeting Pim–1 with monoclonal antibody could be explored for the treatment of leukemia and may represent a novel strategy to overcome drug resistance.

<< Previous
Ex vivo expansion of human hematopoietic stem cells by a...

Next >>
Activation of SHIP via a small molecule agonist kills multiple...

Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 Kinase
Circulation, 11/11/09 Relevance Score: 64%

Expression analysis of Notch-related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis
Scandinavian Journal of Rheumatology, 10/01/09 Relevance Score: 48%

GPR30 and estrogen receptor expression: New insights into hormone dependence of inflammatory breast cancer
Breast Cancer Research and Treatment, 11/16/09 Relevance Score: 47%

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody
Breast Cancer Research and Treatment, 11/04/09 Relevance Score: 47%

MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09 Relevance Score: 47%